Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Airlines concerned that Zika virus may be impacting travel: IATA CEO

A number of airlines have expressed concern that the rapidly spreading Zika virus may be affecting travel, the International Air Transport Association’s Director General and CEO Tony Tyler told reporters on Thursday.   The comment, made on the sidelines of an event hosted by the global airline trade group in New York, marks one of […]

Read More »

Flavonoids in fruits and veggies may help fight weight gain with age

(Reuters Health) – Eating lots of fruits and vegetables rich in flavonoid molecules might help adults minimize weight gain as they age, a recent study suggests. Most plants contain different flavonoids in varying concentrations. Some scientists believe these naturally occurring compounds have antioxidant and anti-inflammatory properties that could help explain some of the health benefits […]

Read More »

AbelsonTaylor, HCB and JUICE Partner with MIT Hacking Medicine

AbelsonTaylor, HCB Health and JUICE Pharma Worldwide Partner with MIT Hacking Medicine To Host MedTech Workshop at 23rd Annual South by Southwest Interactive Festival Three-day event in Austin, TX will bring together healthcare start-ups, entrepreneurs, experts and patients to develop creative solutions for chronic health issues   Austin, TX (February 25, 2016)  Three leading independent […]

Read More »

U.S. Officials Alleged Corrupt Chinese Officials Financially Backed Scheme to Steal GlaxoSmithKline Secrets

PHILADELPHIA – Federal prosecutors alleged that officials within the Chinese government may have been involved in a scheme to steal billions of dollars worth of trade secrets from GlaxoSmithKline (GSK) for use by a China-based company known as Renopharma, the Philadelphia Inquirer reported this morning.   In January five people, including two GlaxoSmithKline employees, were […]

Read More »

Rani Therapeutics Tops $70 Million in Funding With Heavy Hitters like AstraZeneca, Novartis and Google

Rani Therapeutics, headquartered in San Jose, Calif., announced it had closed on its latest funding round, now totaling more than $70 million. Existing investors included Novartis (NVS), Google Ventures, Buttonwood, GF Ventures, KPC Pharmaceuticals, inCube Ventures and VentureHealth. New investors include AstraZeneca (AZN), Virtus Inspire Ventures, and Ping An Ventures. Rani focuses on a development […]

Read More »

Czech Republic reports first two Zika cases

The Czech Republic has identified its first cases of the mosquito-borne Zika virus in two Czechs returning from separate trips to the Caribbean, Health Minister Svatopluk Nemecek said on Thursday.   The World Health Organisation warned Wednesday that the Zika outbreak would likely worsen before any relief comes to the countries besieged by the virus. […]

Read More »

Verily, Vanderbilt named to launch U.S. Precision Medicine pilot

The National Institutes of Health on Thursday named Verily, formerly Google Life Sciences, as advisor to Nashville’s Vanderbilt University in a pilot program to launch the Precision Medicine Initiative outlined by President Barack Obama last year. The program aims to enroll 79,000 volunteer participants by the end of this year to supply personal data that […]

Read More »

AstraZeneca’s $4 billion Acerta deal endorsed by orphan drug status

AstraZeneca’s (AZN.L) bold move to buy 55 percent of privately held biotech firm Acerta Pharma for $4 billion in December has been vindicated, at least in part, by the award of special “orphan” status to the key experimental drug involved.   The drugmaker said on Thursday that the European Medicines Agency had recommended acalabrutinib as […]

Read More »

China pharmacies urge abolition of Alibaba Health drug tracking platform

A group of Chinese pharmacy chains has demanded the abolition of a medicine tracking platform run by Alibaba Health Information Technology, piling further pressure on the firm after China’s drug regulator suspended the system on Saturday. In a joint statement on Wednesday, the 19 firms called for the China Food and Drug Administration (CFDA) to […]

Read More »

FMC aims for 110,000 U.S. patients to be on Mircera in first-quarter

Kidney dialysis provider Fresenius Medical Care (FMC) expects more than 70 percent of eligible U.S. patients to have switched to cheaper alternative anemia treatment Mircera by the end of March, the German group’s chief executive said. About 155,000 of FMC’s 185,000 U.S. dialysis patients require treatment against anemia, or deficiency of red blood cells. The […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom